Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks

John D. Roberts; Stephen Shibata; Darcy V. Spicer; Howard L. McLeod; Mary Beth Tombes; Brenda Kyle; Mary Carroll; Beth Sheedy; Mary A. Collier; Yazdi K. Pithavala; Linda J. Paradiso; Neil J. Clendeninn

作者John D. Roberts; Stephen Shibata; Darcy V. Spicer; Howard L. McLeod; Mary Beth Tombes; Brenda Kyle; Mary Carroll; Beth Sheedy; Mary A. Collier; Yazdi K. Pithavala; Linda J. Paradiso; Neil J. Clendeninn
卷第45卷
期第5期
印刷ISSN0344-5704
电子ISSN1432-0843
文件大小95.13KB
发表时间2000-04
DOI10.1007/s002800051012
页码423-427

发现好书期刊，享受阅读乐趣

Phase I study of AG2034, a targeted GARFT inhibitor, administered once every 3 weeks